All News

Both studies were featured during the American College of Cardiology's annual briefing on results for consumers. They will be presented during the 70th Scientific Session, which is set for May 15-17, 2021.

Using transcranial sonography, researchers uncovered a potential imaging biomarker for depression among migraineurs.

The United States agreed to temporarily suspend COVID-19 vaccine patents; HIV does not appear to impact efficacy of AstraZeneca's COVID-19 vaccine; cases of COVID-19 cases could decrease by July.

Despite overall survival improvements among pediatric patients living with HIV, 20.5% are still lost to follow-up.

A survey by West Health and Gallup found that Black workers and those making less than $48,000 in the United States were more likely to stay in unwanted jobs out of fear of losing their health benefits.

Laryngeal hypersensitivity may be a key factor in refractory and unexplained cough.

Alberta, Canada becomes the latest province to begin switching patients from originator adalimumab (Humira) to biosimilar versions as part of its Biosimilars Initiative.

Factors related to pulmonary and physical activity could serve as predictors for how long patients with chronic obstructive pulmonary disease (COPD) can tolerate during an endurance walk test, potentially leading to more accurate analyses on the effectiveness of interventions.

For each hour that an employee’s work schedule deviated from their natural body clock, their odds of having high cardiovascular risk increased by 31%.

Researchers used data fromThe Environmental Determinants of Diabetes in the Young study to assess whether age impacts risk of T1D onset.

Compared with nonsmokers who did not have recent exposure to secondhand smoke, a 35% greater chance for heart failure was seen among those with recent exposure to the toxic fumes.

Courtney Blair, MD, discusses how COVID-19 has impacted patients with allergies and other respiratory conditions.

Researchers were successful in wirelessly recording the direct brain activity of patients with Parkinson disease, while also showcasing the first demonstration of adaptive deep brain stimulation at home.

The FDA is preparing to authorize the Pfizer/BioNTech COVID-19 vaccine in adolescents aged 12 to 15 years; COVID-19 restrictions on capacity limits are lifting nationwide; children account for more than 1 in 5 new COVID-19 cases.

Robin Gelburd, JD, president of FAIR Health, discusses the sudden decline in telehealth utilization during the first month of 2021.

New research demonstrates that patients with multiple sclerosis (MS) who were asymptomatic for COVID-19 had lower antibody levels against SARS-CoV-2, its causative virus, due to having fewer B cells.

Patients with psoriasis have a higher level of interleukin-30 (IL-30) than healthy patients, according to a recent study.

In a review, researchers examined potential mechanisms contributing to the hereditary nature of migraine.

Frank Martin, PhD, director of research at JDRF, discusses the importance of diabetic ketoacidosis mitigation efforts and appropriate education for parents of children with type 1 diabetes (T1D).

Walgreens, CVS responsible for a majority of wasted US COVID-19 vaccine doses; travel to India restricted by Biden administration amid record daily COVID-19 cases; CDC report links physical adverse events to J&J vaccine with anxiety.

In a recent review, researchers compiled possible reactions and toxicities that span 6 categories.

Ensuring that employees have the assistance and tools necessary to meet telehealth and behavioral health demands is vital to promote safety and health amid the pandemic, along with lowering or eliminating out-of-pocket costs that can steer people away from cancer screenings, therapies, or aspects of high-value care.

Each month of duration of 90% or more improvement in Psoriasis Are and Severity Index significantly impacted patient-reported outcomes in patients with psoriasis.

The current standard calls for bone marrow biopsies, which are invasive and costly.

Although the Center for Medicare and Medicaid Innovation (CMMI) has delayed the start of payment models for kidney care, one dialysis provider says it remains committed to the concept.

Last year, a data monitoring committee halted the DAPA-CKD trial when it found the evidence of efficacy was overwhelming, after it was shown the trial met all its primary and secondary end points for patients with chronic kidney disease, with and without type 2 diabetes.

Despite the FDA approving 29 biosimilars, none have achieved interchangeability status. Boehringer Ingelheim thinks its adalimumab biosimilar, Cyltezo, may be the first.

Patients with the GBA mutation of Parkinson disease (PD) were shown to exhibit more severe cognitive decline than patients with idiopathic PD and those with both the GBA and LRRK2 G2019S mutations of PD.